Filep J, Földes-Filep E, Frölich J C
Br J Pharmacol. 1987 Feb;90(2):431-9. doi: 10.1111/j.1476-5381.1987.tb08973.x.
The pressor and vascular permeability effects of leukotrienes B4 (LTB4), C4 and D4 were investigated in conscious unrestrained rats. Leukotrienes C4 and D4 (3.2-51 nmol kg-1 i.v.) caused an acute dose-dependent elevation of the mean arterial pressure, which was maximal after 2 min and returned to control levels within 14 min. Heart rate was significantly reduced by the higher doses of LTC4 and LTD4. LTB4 (up to a dose of 51 nmol kg-1) was essentially inactive. These effects of LTC4 and LTD4 were abolished by FPL 55712, a putative antagonist of sulphidopeptide leukotrienes and by verapamil, a calcium channel blocker. Indomethacin, phentolamine or saralasin pretreatment failed to modify the pressor response to LTC4 and LTD4. LTC4 and LTD4 furthermore caused an increase in haematocrit values, which was significantly attenuated by FPL 55712, indomethacin and verapamil. The present findings show that the pressor effect of LTC4 and LTD4 is not related to prostanoid release and can be reversed by calcium channel blockade; whereas the effect on vascular permeability seems to require the presence of both cyclo-oxygenase product(s) and calcium.
在清醒自由活动的大鼠中研究了白三烯B4(LTB4)、C4和D4的升压及血管通透性作用。白三烯C4和D4(静脉注射3.2 - 51 nmol kg-1)引起平均动脉压急性剂量依赖性升高,2分钟后达到最大值,并在14分钟内恢复到对照水平。较高剂量的LTC4和LTD4可显著降低心率。LTB4(剂量高达51 nmol kg-1)基本无活性。LTC4和LTD4的这些作用被FPL 55712(一种推测的硫肽白三烯拮抗剂)和维拉帕米(一种钙通道阻滞剂)消除。吲哚美辛、酚妥拉明或沙拉新预处理未能改变对LTC4和LTD4的升压反应。此外,LTC4和LTD4导致血细胞比容值升高,FPL 55712、吲哚美辛和维拉帕米可显著减弱这种升高。目前的研究结果表明,LTC4和LTD4的升压作用与前列腺素释放无关,可通过钙通道阻滞逆转;而对血管通透性的作用似乎需要环氧化酶产物和钙的共同存在。